| Literature DB >> 34943281 |
Giovanni Boscarino1, Maria Giulia Conti1,2, Federica Pagano1, Maria Di Chiara1, Chiara Pannucci1, Elisa Onestà1, Rita Prota1, Giorgia Deli1, Lucia Dito1, Daniela Regoli1, Salvatore Oliva1, Gianluca Terrin1.
Abstract
Evidences demonstrated that timing of weaning influences long-term growth in full term infants. However, studies on preterm infants are still lacking, and the international guidelines are focused only on healthy full-term newborn, without consensus for preterms. We aimed at evaluating, in a cohort study, the consequences of different timing of weaning on auxological outcomes up to 12 months of corrected age in a population of neonates born with gestational age < 32 weeks or birth weight < 1500 g. We divided the enrolled neonates in two cohorts according to the timing of weaning: (i) Early Weaning: introduction of complementary food before 6 months of corrected age; (ii) Late Weaning: complementary food introduced after 6 months of corrected age. Growth parameters (weight, length, body mass index, and ponderal index) were measured at 12 months of life. The two groups were statistically comparable for baseline clinical characteristics, and differences on growth parameters were not reported between the two study groups. These results were confirmed in linear and binary logistic regression multivariate models. Timing of weaning is not related to growth of preterm newborns in the first 12 months of corrected age. Studies are needed to reach consensus for the appropriate nutritional approach for preterm babies after discharge.Entities:
Keywords: VLBW; body mass index; body weight; breastfeeding; complementary food; follow-up; infant formula; length; microflora; neonatology; nutrition; weaning
Year: 2021 PMID: 34943281 PMCID: PMC8700469 DOI: 10.3390/children8121085
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Figure 1Flow-chart.
Baseline clinical characteristics of the study population.
| Group 1 | Group 2 | |
|---|---|---|
| Maternal age, years | 36 (34 to 37) | 35 (35 to 36) |
| Intrauterine growth restriction, No (%) | 5 (8.2) | 11 (11.8) |
| Birth weight, grams | 1337 (1248 to 1427) | 1249 (1184 to 1313) |
| Gestational age, week | 29 (29 to 30) | 29 (29 to 30) |
| Small for gestational age at birth, No (%) | 10 (16.4) | 17 (18.3) |
| Antenatal steroids a, No. (%) | 36 (59.0) | 68 (73.1) |
| Cesarean section, No. (%) | 53 (86.9) | 85 (91.4) |
| Male sex, No. (%) | 36 (59.0) | 43 (46.2) |
| Twins, No. (%) | 20 (32.8) | 35 (37.6) |
| 5-min Apgar score | 8 (7 to 8) | 8 (7 to 8) |
| pH at birth | 7.3 (7.2 to 7.3) | 7.3 (7.2 to 7.3) |
| CRIB II score | 5 (5 to 6) | 6 (5 to 7) |
| Extrauterine growth restriction at 36 weeks of PMA, No. (%) | 43 (70.5) | 66 (71.0) |
Table legend. a Intramuscular steroid cycle in two doses of 12 mg over a 24-h period; CRIB (clinical risk index for babies); PMA (postmenstrual age). Data are shown as mean (95% confidence interval) when not specified.
Morbidity rate of the study population.
| Group 1 | Group 2 | |
|---|---|---|
| Morbidity a | 15 (24.6) | 26 (28.0) |
| Necrotizing enterocolitis | 2 (3.3) | 3 (3.2) |
| Intraventricular hemorrhage | 1 (1.6) | 4 (4.3) |
| Periventricular Leukomalacia | 0 (0.0) | 2 (2.2) |
| Sepsis proven by positive cultures | 1 (1.6) | 6 (6.5) |
| Retinopathy of prematurity | 11 (18.0) | 18 (19.4) |
| Bronchopulmonary dysplasia | 3 (4.9) | 3 (3.2) |
| Invasive mechanical ventilation | 20 (32.8) | 21 (22.6) |
| Non-invasive mechanical ventilation | 45 (73.8) | 74 (79.8) |
Table legend. a at least one prematurity-related morbidity (necrotizing enterocolitis or intraventricular hemorrhage or periventricular leukomalacia or sepsis proven by positive cultures or retinopathy of prematurity or bronchopulmonary dysplasia). Data are shown as number (percentage).
Nutritional management of the study population.
| Group 1 | Group 2 | |
|---|---|---|
| Full enteral feeding, days of life | 14 (11 to 17) | 14 (11 to 18) |
| Start of enteral nutrition before 72 h of life, No. (%) | 50 (82.0) | 81 (87.1) |
| Duration of parenteral nutrition, days | 13 (10 to 15) | 12 (10 to 14) |
| Exclusive breastfeeding up to weaning, No. (%) | 5 (8.2) * | 1 (1.1) |
| Exclusive infant formula up to weaning, No. (%) | 14 (23.0) | 15 (16.1) |
| Duration of breastfeeding, weeks | 4 (2 to 6) | 5 (2 to 8) |
| Age of weaning, months | 4 (4 to 5) * | 6 (6 to 7) |
Notes. * p-value < 0.05 vs. group 2. Data are shown as mean (95% confidence interval) when not specified.
Growth parameters at 12 months of corrected age.
| Group 1 | Group 2 | |
|---|---|---|
| Body weight, grams | 8848 (8444 to 9251) | 9031 (8746 to 9317) |
| Body weight Z-Score | −0.6 (−1.0 to −0.1) | −0.3 (−0.5 to −0.1) |
| Length, cm | 74.3 (73.4 to 75.1) | 73.5 (72.6 to 74.4) |
| Length Z-Score | 0 (−0,4 to 0.3) | −0.2 (−0.5 to 0.1) |
| Body mass index | 16 (15 to 17) | 17 (16 to 17) |
| Body mass index Z-Score | −0.8 (−1.3 to −0.2) | −0.2 (−0.5 to 0) |
| Ponderal Index | 22 (21 to 23) | 23 (22 to 23) |
Notes. Data are shown as mean (95% confidence interval).
Linear regression analysis to evaluate the influence of confounding variables on primary outcome.
| Dependent Variables | Confounding Variables | B | β | 95% Confidence Interval | ||
|---|---|---|---|---|---|---|
| Male newborns | Body weight Z-Score | Maternal age | −0.023 | 0.542 | −0.613 | −0.097 to 0.051 |
| Gestational age at birth | −0.013 | 0.906 | −0.119 | −0.235 to 0.209 | ||
| Duration of breastfeeding | 0.000 | 0.995 | 0.007 | −0.064 to 0.065 | ||
| Age of weaning | 0.256 | 0.063 | 1.890 | −0.014 to 0.526 | ||
| Length Z-Score | Maternal age | 0.018 | 0.530 | 0.631 | −0.040 to 0.077 | |
| Gestational age at birth | 0.012 | 0.894 | 0.133 | −0.162 to 0.186 | ||
| Duration of breastfeeding | −0.019 | 0.449 | −0.762 | −0.070 to 0.031 | ||
| Age of weaning | 0.098 | 0.358 | 0.926 | −0.113 to 0.310 | ||
| Body mass index Z-Score | Maternal age | −0.043 | 0.362 | −0.917 | −0.136 to 0.050 | |
| Gestational age at birth | −0.026 | 0.850 | −0.190 | −0.304 to 0.251 | ||
| Duration of breastfeeding | 0.013 | 0.741 | 0.331 | −0.067 to 0.094 | ||
| Age of weaning | 0.254 | 0.137 | 1.503 | −0.083 to 0.251 | ||
| Female newborns | Body weight Z-Score | Maternal age | 0.008 | 0.775 | 0.288 | −0.049 to 0.066 |
| Gestational age at birth | −0.004 | 0.947 | −0.067 | −0.133 to 0.124 | ||
| Duration of breastfeeding | 0.006 | 0.586 | 0.547 | −0.015 to 0.026 | ||
| Age of weaning | 0.015 | 0.832 | 0.213 | −0.123 to 0.152 | ||
| Length Z-Score | Maternal age | 0.036 | 0.285 | 1.078 | −0.031 to 0.103 | |
| Gestational age at birth | −0.053 | 0.484 | −0.704 | −0.203 to 0.097 | ||
| Duration of breastfeeding | 0.007 | 0.540 | 0.616 | −0.106 to 0.031 | ||
| Age of weaning | −0.010 | 0.901 | −0.124 | −0.171 to 0.151 | ||
| Body mass index Z-Score | Maternal age | −0.019 | 0.482 | −0.708 | −0.073 to 0.035 | |
| Gestational age at birth | 0.034 | 0.569 | 0.573 | −0.085 to 0.154 | ||
| Duration of breastfeeding | 0.001 | 0.897 | 0.131 | −0.018 to 0.020 | ||
| Age of weaning | 0.034 | 0.600 | 0.527 | −0.094 to 0.162 |
Binary logistic regression analysis to evaluate the influence of confounding variables on primary outcome.
| Dependent Variables | Confounding Variables | B | O.R. (95% Confidence Interval) | |
|---|---|---|---|---|
| Body weightZ-Score < −1 | Intrauterine growth restriction | 0.338 | 0.574 | 1.402 (0.432 to 4.549) |
| Born before 28 weeks of gestational age | 0.354 | 0.407 | 1.425 (0.617 to 3.292) | |
| Male sex | 0.003 | 0.993 | 1.003 (0.468 to 2.149) | |
| Morbidity a | 0.169 | 0.695 | 1.184 (0.509 to 2.754) | |
| Extrauterine growth restriction | 0.604 | 0.186 | 1.830 (0.747 to 4.483) | |
| Exclusive breastfeeding up to weaning | 0.127 | 0.890 | 1.135 (0.188 to 6.836) | |
| Group 2 (Late weaning) | −0.374 | 0.332 | 0.688 (0.323 to 1.464) | |
| LengthZ-Score < −1 | Intrauterine growth restriction | 0.739 | 0.202 | 2.094 (0.673 to 6.515) |
| Born before 28 weeks of gestational age | 0.273 | 0.545 | 1.314 (0.542 to 3.185) | |
| Male sex | 0.246 | 0.541 | 1.280 (0.581 to 2.819) | |
| Morbidity a | −0.320 | 0.496 | 0.726 (0.289 to 1.825) | |
| Extrauterine growth restriction | 0.561 | 0.228 | 1.753 (0.704 to 4.364) | |
| Exclusive breastfeeding up to weaning | 0.181 | 0.844 | 1.198 (0.197 to 7.294) | |
| Group 2 (Late weaning) | −0.304 | 0.446 | 0.738 (0.338 to 1.613) | |
| Body mass indexZ-Score < −1 | Intrauterine growth restriction | −0.527 | 0.447 | 0.591 (0.152 to 2.293) |
| Born before 28 weeks of gestational age | −0.173 | 0.702 | 0.841 (0.347 to 2.040) | |
| Male sex | 0.365 | 0.353 | 1.440 (0.667 to 3.111) | |
| Morbidity a | 0.347 | 0.428 | 1.414 (0.600 to 3.334) | |
| Extrauterine growth restriction | 0.667 | 0.151 | 1.948 (0.783 to 4.846) | |
| Exclusive breastfeeding up to weaning | −0.974 | 0.397 | 0.378 (0.040 to 3.598) | |
| Group 2 (Late weaning) | −0.584 | 0.131 | 0.558 (0.261 to 1.191) |
Notes. a at least one prematurity-related morbidity (necrotizing enterocolitis or intraventricular hemorrhage or periventricular leukomalacia or sepsis proven by positive cultures or retinopathy of prematurity or bronchopulmonary dysplasia).